PATENT CLAIM ANALYSIS

Application Number: 15895872
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "043000"]

Abstract:
Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection, with a nucleoside, a nucleotide and an analog thereof.

Claim (Index 71):
A method for ameliorating or treating a paramyxovirus viral infection in combination with one or more agents comprising administering to or contacting a cell in a subject identified as suffering from the paramyxovirus viral infection with an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 88.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14312990', '13721988', '15215434', '13236486', '14386294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7959303797416729
- 35 USC 102 Novelty (BERT): 0.5330313666260235
- Combined Prediction Score: 0.769640478430108
- Mean Citation Score: 358.02125000000007
- Max Citation Score: 369.378
- Similarity Product: 325.4957452254295

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test